The -675 4G/5G polymorphism in plasminogen activator inhibitor-1 gene is associated with risk of asthma: a meta-analysis.

ABSTRACT: BACKGROUND: A number of studies assessed the association of -675 4G/5G polymorphism in the promoter region of plasminogen activator inhibitor (PAI)-1 gene with asthma in different populations. However, most studies reported inconclusive results. A meta-analysis was conducted to investigate the association between polymorphism in the PAI-1 gene and asthma susceptibility. METHODS: Databases including Pubmed, EMBASE, HuGE Literature Finder, Wanfang Database, China National Knowledge Infrastructure (CNKI) and Weipu Database were searched to find relevant studies. Odds ratios (ORs) with 95% confidence intervals (CIs) were used to assess the strength of association in the dominant model, recessive model, codominant model, and additive model. RESULTS: Eight studies involving 1817 cases and 2327 controls were included. Overall, significant association between 4G/5G polymorphism and asthma susceptibility was observed for 4G4G+4G5G vs. 5G5G (OR?=?1.56, 95% CI 1.12-2.18, P?=?0.008), 4G/4G vs. 4G/5G+5G/5G (OR?=?1.38, 95% CI 1.06-1.80, P?=?0.02), 4G/4G vs. 5G/5G (OR?=?1.80, 95% CI 1.17-2.76, P?=?0.007), 4G/5G vs. 5G/5G (OR?=?1.40, 95% CI 1.07-1.84, P?=?0.02), and 4G vs. 5G (OR?=?1.35, 95% CI 1.08-1.68, P?=?0.008). CONCLUSIONS: This meta-analysis suggested that the -675 4G/5G polymorphism of PAI-1 gene was a risk factor of asthma.

SUBMITTER: Nie W 

PROVIDER: S-EPMC3313978 | biostudies-literature | 2012

REPOSITORIES: biostudies-literature